Cao Sean Wuxiong
SEC CIK 2109966 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NBP | NovaBridge Biosciences | See Remarks, Dir | 266.5K | — | $122.5K | 3 | 2026-05-14 | 2026-09-09 |
Most active insiders at NBP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hagler Mark Arnold | See Remarks | $577.3K | — |
| 2 | Cao Sean Wuxiong | See Remarks, Dir | — | $122.5K |
| 3 | Xu Cong Claire | SVP, Clinical Development | — | $20.4K |
| 4 | Dennis Phillip Andrew | Chief Medical Off | — | $11.4K |
| 5 | Lenz Robert A. | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 16:30 | 2026-09-09 | NBP | NovaBridge Biosciences | Cao Sean Wuxiong | Chief Bus. Development Off | S - Sale | $0.74 | -108.0K | 266.5K | -29% | -$79.9K | |
| DM | 2026-09-08 17:51 | 2026-09-03 | NBP | NovaBridge Biosciences | Cao Sean Wuxiong | Chief Bus. Development Off | M - OptEx | — | +339.4K | 374.4K | +968% | — |
| 2026-05-18 16:05 | 2026-05-14 | NBP | NovaBridge Biosciences | Cao Sean Wuxiong | See Remarks, Dir | S - Sale | $1.99 | -21.4K | 35.1K | -38% | -$42.6K |
Purchase Sale Sale after option exercise All abbreviations